Author

M. Khasraw

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

P. E. Fecci· 2 shared A. Iavarone· 1 shared A. M. E. Walenkamp· 1 shared A. Miggelbrink· 1 shared A. Mohan· 1 shared B. H. Shaz· 1 shared B. J. Puviindran· 1 shared C. O. Railton· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

P. E. Fecci

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models

K. Singh, K. M. Hotchkiss, S. L. Cook, P. Noldner, Y. Zhou, E. M. Moelker, C. O. Railton, E. E. Blandford, B. J. Puviindran, S. E. Wallace, P. K. Norberg, G. E. Archer, B. H. Shaz, K. Ayasoufi, J. H. Sampson, , P. E. Fecci

This study shows that IL-7-expanded autologous lymphocytes increase VLA-4 expression and accumulate in glioblastoma tumors, enhancing the effectiveness of T cell-based therapies.

bioRxiv · Apr 1, 2024Cancer Biology

A Novel MHC-Independent Mechanism of Tumor Cell Killing by CD8+ T Cells

E. C. Lerner, K. Woroniecka, V. D'Anniballe, D. Wilkinson, S. Lorrey, J. W. Polania, L. Wachsmuth, A. Miggelbrink, J. Raj, W. Tomaszewski, A. Mohan, X. Cui, M. Khasraw, M. D. Gunn, P. E. Fecci

This study shows CD8+ T cells can kill MHC-I-deficient tumor cells via NKG2D-NKG2DL interactions, independent of antigen recognition, and identifies this pathway as a potential therapeutic target.

bioRxiv · Feb 2, 2023 · PreprintImmunology

Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment

F. S. Varn, K. C. Johnson, T. E. Wade, T. M. Malta, T. S. Sabedot, F. P. Barthel, H. Kim, N. Ahmed, I. Datta, J. S. Barnholtz-Sloan, S. Bakas, F. D'Angelo, H. K. Gan, L. Garofano, J. T. Huse, , The GLASS Consortium

This study analyzes longitudinal glioma data to identify recurrence-associated changes in genetics and microenvironment linked to therapy resistance.

bioRxiv · May 3, 2021Cancer Biology